Autoantibody prevalence in active tuberculosis: Reactive or pathognomonic?

BMJ Open

Volumn 3, Issue 7, 2013, Pages

  Shen, Chieh Yu ^a   Hsieh, Song Chou ^a   Yu, Chia Li ^a   Wang, Jann Yuan ^a   Lee, Li Na ^a   Yu, Chong Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CENTROMERE ANTIBODY; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOUBLE STRANDED DNA ANTIBODY; ETHAMBUTOL; HLA B27 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; ISONIAZID; LA ANTIBODY; PYRAZINAMIDE; RIBONUCLEOPROTEIN ANTIBODY; RIFAMPICIN; RO ANTIBODY; SCL 70 ANTIBODY; SM ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; COUGHING; DYSPNEA; FEMALE; FEVER; FOLLOW UP; HEMOPTYSIS; HUMAN; LUNG CAVITATION; LUNG INFILTRATE; MALAISE; MALE; NIGHT SWEAT; PLEURA EFFUSION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SPUTUM; TAIWAN; TERTIARY HEALTH CARE; THORAX PAIN; TREATMENT DURATION; TUBERCULOSIS; WEIGHT REDUCTION;

EID: 84883393878     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002665     Document Type: Review

References (31)

1. Elkayam O, Caspi D, Lidgi M, et al. Auto-antibody profiles in patients with active pulmonary tuberculosis. Int J Tuberc Lung Dis 2007;11: 306-10. (Pubitemid 46447439)
2. Adebajo AO, Charles P, Maini RN, et al. Autoantibodies in malaria, tuberculosis and hepatitis B in a west African population. Clin Exp Immunol 1993;92: 73-6. (Pubitemid 23113902)
3. Ganesh R, Ramalingam V, Eswara Raja T, et al. Antinuclear antibodies in Mycobacterium tuberculosis infection. Indian J Pediatr 2008;75:1188.
4. Kasikovic-Lecic S, Kerenji A, Pavlovic S, et al. Autoantibodies in patients treated for active pulmonary tuberculosis. Med Pregl 2008;61: 333-42.
5. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69: 1580-8.
6. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48: 2741-9. (Pubitemid 37280601)
7. Lu K-T, eds. Taiwan guidelines for TB diagnosis and treatment. Taipei, Taiwan: Centers for Disease Control, R.O.C. (Taiwan), 2011.
8. Laniado-Laborin R, Cabrales-Vargas N. Tuberculosis in healthcare workers at a general hospital in Mexico. Infect Control Hosp Epidemiol 2006;27: 449-52. (Pubitemid 43835525)
9. Wang JY, Shu CC, Lee CH, et al. Interferon-gamma release assay and Rifampicin therapy for household contacts of tuberculosis. J Infect 2012;64: 291-8.
10. Hayashi N, Koshiba M, Nishimura K, et al. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol 2008;18: 153-60.
11. Siegel RM, Lipsky PE. Autoimmunity. In: Firestein MGS, Budd RC, Harris ED Jr, Mclnnes IB, Ruddy S, Sergent JS, MD. eds. Kelley's textbook of rheumatology. Philadelphia: Elsevier Inc, 2009:270.
12. Powell AM, Black MM. Epitope spreading: protection from pathogens, but propagation of autoimmunity? Clin Exp Dermatol 2001;26: 427-33. (Pubitemid 32863100)
13. Peng SL, Craft JE. Antinuclear antibodies. In Firestein MGS, Budd RC, Harris ED Jr, Mclnnes IB, Ruddy S, Sergent JS, MD. eds. Kelley's textbook of rheumatology. Philadelphia: Elsevier, 2009:1623.
14. Tassiulas IO, Boumpas DT. Clinical features and treatment of systemic lupus erythematosus. In: Firestein MGS, Budd RC, Harris ED Jr, Mclnnes IB, Ruddy S, Sergent JS, MD. eds. Kelley's textbook of theumatology. Philadelphia: Elsevier, 2009:1273.
15. Kuhn KA, Kulik L, Tomooka B, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006;116: 961-73.
16. Varga J, Denton CP. Systemic sclerosis and the scleroderma-spectrum disorders. In: Firestein MGS, Budd RC, Harris ED Jr, Mclnnes IB, Ruddy S, Sergent JS, MD. eds. Kelley's textbook of rheumatology. Philadelphia: Elsevier, 2009:1323.
17. Nagaraju K, Lundberg IE. Inflammatory disease of muscle and other myopathies. In: Firestein MGS, Budd RC, Harris ED Jr, Mclnnes IB, Ruddy S, Sergent JS, MD. eds. Kelley's textbook of rheumatology. Philadelphia: Elsevier, 2009:1356.
18. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30: 633-8.
19. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4: 295-306.
20. Faldt J, Dahlgren C, Karlsson A, et al. Activation of human neutrophils by mycobacterial phenolic glycolipids. Clin Exp Immunol 1999;118: 253-60. (Pubitemid 29519256)
21. Gasser O, Hess C, Miot S, et al. Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp Cell Res 2003;285: 243-57. (Pubitemid 36432112)
22. Lopez LR, Dier KJ, Lopez D, et al. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. Am J Clin Pathol 2004;121: 142-9. (Pubitemid 38090165)
23. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335: 1544-7. (Pubitemid 20189625)
24. Deane KD, West SG. Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review. Semin Arthritis Rheum 2005;35: 154-65. (Pubitemid 41713955)
25. Almerico Marruchella AC, Tommasi C, Lauria FN, et al. A case of pulmonary tuberculosis presenting as diffuse alveolar haemorrhage: is there a role for anticardiolipin antibodies? BMC Infect Dis 2010;10:33.
26. Erkan D, Lockshin MD. Non-criteria manifestations of antiphospholipid syndrome. Lupus 2010;19: 424-7.
27. Guldner HH, Szostecki C, Vosberg HP, et al. Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I. Chromosoma 1986;94: 132-8.
28. Shero JH, Bordwell B, Rothfield NF, et al. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science 1986;231: 737-40. (Pubitemid 16104048)
29. Rizou C, Ioannidis JP, Panou-Pomonis E, et al. B-Cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis. Am J Respir Cell Mol Biol 2000;22: 344-51. (Pubitemid 30343361)
30. Annamalai T, Dani N, Cheng B, et al. Analysis of DNA relaxation and cleavage activities of recombinant Mycobacterium tuberculosis DNA topoisomerase I from a new expression and purification protocol. BMC Biochem 2009;10:18.
31. Narula G, Becker J, Cheng B, et al. The DNA relaxation activity and covalent complex accumulation of Mycobacterium tuberculosis topoisomerase I can be assayed in Escherichia coli: application for identification of potential FRET-dye labeling sites. BMC Biochem 2010;11:41.